In cancer care, accurate tools for predicting whether a tumour will metastasise can help patients receive the most appropriate treatments. But...

New AI tool, maps cancer cell diversity into five key types, unlocking the potential for personalized treatment and improved outcomes in breast...

The number of patients receiving cancer treatments on time and within targets has hit its lowest point since records began in 2012.

The number of patients receiving cancer treatments on time and within targets has hit its lowest point since records began in 2012.

The number of patients receiving cancer treatments on time and within targets has hit its lowest point since records began in 2012.

Brazilian scientists have identified a molecule, BamazScplp1, in Amazonian scorpion venom that effectively kills breast cancer cells in early tests....

The ESR1 mutated metastatic breast cancer diagnostics market is valued at USD 64.61 million in 2025 and is slated to reach USD 92.92 million by 2035,...

The ESR1 mutated metastatic breast cancer diagnostics market is valued at USD 64.61 million in 2025 and is slated to reach USD 92.92 million by 2035,...

What if we told you that not all cancer cells in a tumour are the same-and that's exactly why some treatments fail? A groundbreaking AI tool called...

When cancer spreads from a primary tumour to new sites throughout the body, it undergoes changes that increase its genetic complexity. A new study...